CROs can contribute to site collaboration by also identifying and supporting non-academic institutions capable of conducting ...

As the industry prioritises health equity and inclusion in clinical research ... get-go will be the key to opening the treasure box of tangible benefits of DCTs for all stakeholders.

CTI grew from a Cincinnati startup to a global leader in clinical research. CEO Tim Schroder shares insights on its success ...

C linical research is an essential piece of medical innovation— and yet it is inaccessible to far too many people. For too long, clinical ... Alongside industry stakeholders, the organization ...

LaShell Robinson, head of global feasibility and trial equity at Takeda, identifies some of the key barriers in achieving ...

One of the key themes of the WHO guidance is ensuring ... The paper discusses the need for harmonisation between stakeholders in clinical trials to try and improve accessibility to research ...

A key session on day one will delve into ... a critical aspect of managing complex clinical trials. As stakeholders demand ...

A new review finds federally qualified health centers (FQHCs) are underutilized in hypertension and type 2 diabetes clinical ...

Molecure achieved key milestones in the development of its innovative therapies in 2024 and plans to accelerate research and development in its most advanced clinical programs: OATD-01 and OATD-02.